Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Xinyu Gui"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16793-16804 (2023)
Abstract Introduction Eribulin is currently recommended for the treatment of patients with metastatic breast cancer (MBC) pre‐treated with taxanes and anthracyclines. The aim of the present study was to evaluate the effectiveness and safety of erib
Externí odkaz:
https://doaj.org/article/0769be56df2043f48e18f05a3728ef21
Autor:
Ruyan Zhang, Yifei Chen, Xiaoran Liu, Xinyu Gui, Anjie Zhu, Hanfang Jiang, Bin Shao, Xu Liang, Ying Yan, Jiayang Zhang, Guohong Song, Huiping Li
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesThis study evaluated the efficacy and safety of apatinib (an oral small-molecule tyrosine kinase inhibitor targeting VEGFR-2) 250 mg combined with chemotherapy in patients with pretreated metastatic breast cancer in a real-world setting.Pat
Externí odkaz:
https://doaj.org/article/90bbfa76e4234f49859e0a0e94aff489
Autor:
Hanfang Jiang, Ruyan Zhang, Xiaoran Liu, Ran Ran, Jiayang Zhang, Yaxin Liu, Xinyu Gui, Yifei Chen, Kun Li, Bin Shao, Ying Yan, Xu Liang, Guohong Song, Lijun Di, Huiping Li
Publikováno v:
Cancer Medicine, Vol 10, Iss 17, Pp 6089-6098 (2021)
Abstract Bilateral breast cancer (BBC) is an uncommon subset of breast cancer (BC), and it may present as synchronous bilateral breast cancer (sBBC) or metachronous bilateral breast cancer (mBBC). Through this study, we aimed to evaluate the proporti
Externí odkaz:
https://doaj.org/article/f471d173616944f582224d20c66be6fb
Autor:
Hanfang Jiang, Huiping Li, Guohong Song, Lijun Di, Bin Shao, Ying Yan, Xiaoran Liu, Yifei Chen, Ruyan Zhang, Ran Ran, Yaxin Liu, Xinyu Gui, Nan Wang, Huan Wang
Publikováno v:
Breast Cancer Research and Treatment. 199:67-79
Purpose To evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) heavily pretreated with anthracycline and taxanes. Methods I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c00d7a9c1b112291548b91bdb0e886cf
https://doi.org/10.1007/s10549-023-06894-3
https://doi.org/10.1007/s10549-023-06894-3
Publikováno v:
Volume 14: Computer Code Verification and Validation; Nuclear Education and Public Acceptance.
Nuclear power, as a clean energy source, has been facing a blow after the Fukushima nuclear accident. Low public acceptance has severely restricted the nuclear power industry’s development. China government attaches great importance to the public a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f47fae1181213636cbed8d9e94fadaff
https://doi.org/10.1115/icone29-89328
https://doi.org/10.1115/icone29-89328
Autor:
Guohong Song, Hanfang Jiang, Cuizhi Geng, Maorong Wei, Huiping Li, Ran Ran, Zhongshen Tong, Ruyan Zhang, Yaxin Liu, Xinyu Gui, Lu Xue, Junlan Yang
Publikováno v:
Cancer Research. 80:P1-19
Background: Angiogenesis is a key mechanism of tumour growth. Apatinib is an oral tyrosine kinase inhibitor that selectively inhibits vascular endothelial growth factor receptor 2 (VEGFR-2) and blocks downstream signalling and inhibiting tumour angio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b574c381b05ef12f81004195e79b19c5
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-40
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-40
Autor:
Jiaxin Niu, Yong Huang, Huiping Li, Lu Tan, Yue Zhang, Feng Xie, Hao Liao, Jianjun Yu, Xinyu Gui, Yaxin Liu, Nan Wang, Jiayang Zhang
Publikováno v:
Cancer Research. 81:PS16-08
Background: Genetic testing for patients with breast cancer (BCa) patients may change the routine patient care and shift the paradigm towards more personalized managing and treatment strategies. In particular, testing germline mutations in BRCA1/2 ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc57ed70dc1ad5c3bee24a5271f52118
https://doi.org/10.1158/1538-7445.sabcs20-ps16-08
https://doi.org/10.1158/1538-7445.sabcs20-ps16-08
Autor:
Hanfang Jiang, Guohong Song, Zhongsheng Tong, Hongmei Zhao, Cuizhi Geng, Huiping Li, Junlan Yang, Kun Li, Jing Wang, Qianyu Liu, Xinyu Gui, Fangyuan Zhao, Xu Liang, Jiayang Zhang, Yaxin Liu, Guoliang Chen
Publikováno v:
Chinese Journal of Cancer Research
Objective Breast cancer (BC) with chest wall metastasis (CWM) usually shows rich neovascularization. This trial explored the clinical effect of apatinib on human epidermal growth factor receptor 2 (HER2)-negative advanced BC involving CWM. Methods Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa047f099c1ea93b278ce500d1cf2b2
https://pubmed.ncbi.nlm.nih.gov/34158743
https://pubmed.ncbi.nlm.nih.gov/34158743
Autor:
Xiao-Ran Liu, Davis Andrew, Feng Xie, Xinyu Gui, Yifei Chen, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Ami N Shah, Amir Behdad, Firas Wehbe, Yong Huang, Jianjun Yu, Pan Du, Shidong Jia, Huiping Li, Massimo Cristofanilli
Purpose: Comparison of mutation landscape across ethnics using the identical detecting platform is important. We explored the differential genomic landscape of patients with hormone-receptor positive (HR+), HER2-negative MBC of first line recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73af8c76dac5fba34bee783d5bc7291f
https://doi.org/10.21203/rs.3.rs-120555/v2
https://doi.org/10.21203/rs.3.rs-120555/v2
Autor:
Massimo Cristofanilli, Feng Xie, Firas Wehbe, Yong Huang, Youbin Zhang, Xiaoran Liu, Lorenzo Gerratana, Jianjun Yu, Yifei Chen, Andrew M. Davis, Amir Behdad, Shidong Jia, Huiping Li, Qiang Zhang, Ami N. Shah, Pan Du, Xinyu Gui
Publikováno v:
Breast Cancer Research and Treatment
Purpose Meaningful comparison of mutational landscapes across ethnic groups requires the use of standardized platform technology. We have used a harmonized NGS-based liquid biopsy assay to explore the differential genomic landscape of patients with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bbbeb3edf0807127c03d2b21b426416
https://pubmed.ncbi.nlm.nih.gov/34471951
https://pubmed.ncbi.nlm.nih.gov/34471951